NEW YORK (GenomeWeb) – Microbiome health management firm DayTwo announced on Tuesday that it has raised $12 million in a Series A financing round. Participants in the round include Johnson & Johnson Innovation-JJDC, Seventure Partners, the Mayo Clinic, DayTwo Cofounder Marius Nacht, and other private investors. DayTwo has raised $17 million to date.
Israeli healthtech ##nology has raised $ 12 million in a Series A financing round , featuring partners & Johnson Innovation - partners , the Mayo Clinic , DayTwo Co - founder Marius Nacht and Seventure Partners , to name some . DayTwo 's app offers users personalised nutrition products , based on the DNA sequencing of a customer 's gut bacteria . The funds will be used to develop the product , as well as add to engineering , and data science courses in healthcare Aviv and San Francisco .